RSI News

Announcements & Updates

Principles of risk decision-making

August 19, 2022

RSI investigators propose fundamental principles of risk decision-making, and explore their application in a range of real-world risk decision-making contexts. These ten principles will provide valuable guidance on addressing current and future risk issues facing civil societies worldwide.

Read More

Risk of Myocarditis and Pericarditis

May 11, 2022

Using data from the US Centers for Disease Control (CDC) Vaccine Adverse Event Reporting System, RSI investigators collaborated on a study showing increased risks of myopericarditis – an inflammatory condition of the heart muscle – following mRNA COVID19 vaccination, with the highest risks seen in young males following a second…

Read More

Quinolones and risk of retinal detachment

April 26, 2022

Following previous work on the potential risk of acute liver failure associated with quinolone antibiotics, RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski evaluated the potential risk of retinal detachment (RD) associated with these medications. Although no cases of RD were linked to quinolones in clinical trials, some…

Read More

IAI climate change report

April 12, 2022

The International Aluminium Institute (IAI) recently commissioned Climate Risk Institute (CRI) and Risk Sciences International (RSI) to produce a series of informational tools evaluating and explaining the future effects of climate change on the aluminium sector’s sustainability. A principle focus of the project was to highlight one of the most…

Read More

Quinolones and risk of acute liver failure

April 12, 2022

Quinolones, are a class of widely used and popular powerful antibiotics with broad coverage. RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski, recently published a series of three papers on investigating the risk of acute liver failure (ALF) following systemic administration of quinolones, based on a synthesis…

Read More

RSI launches Global Risk Census

March 1, 2022

Risk Sciences International has launched The Global Risk Census. The goal of the Census is to provide insights into important risks that need to be confronted now and in the future. These insights will be of great value to decision-makers, policy-makers and indeed to all stakeholders affected by a myriad…

Read More

US FDA FAERS and quinolones

June 22, 2021

Some case reports on Quinolones, a potent and globally popular group of antibiotics that are used to treat a wide range of infections, have raised concern about their possible association with acute hepatic failure (AHF). Data from the US FDA Adverse Event Reporting System were evaluated for signals of AHF…

Read More

Advancing Toxicity Testing webinar

May 25, 2021

The Center for Alternatives to Animal Testing and the Animal-Free Safety Assessment recently held their annual meeting on advancing toxicity testing in the 21st century (TT21C). This informal event provided brief updates on cutting edge approaches in toxicology that have accrued since the publication of the 2007 U.S. National Research…

Read More

USC appoints Dr. Mattison distinguished professor

March 16, 2021

Dr. Donald Mattison, RSI’s Senior Vice-President and Chief Medical Officer, has accepted an appointment as a University of South Carolina Health Sciences Distinguished Professor in the in the Arnold School of Public Health (ASPH).  The appointment noted that Dr. Mattison’s broad and deep career experience as a researcher and educator is impressive and…

Read More
Special announcements sign-up

Stay informed

Click here if you would like to sign up to receive occasional updates from RSI
(max. four times a year).